Cession Oncology
PrivateCompany Overview
Cession Oncology is a biotechnology company developing targeted RNA therapeutics for pancreatic cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cession Oncology Comparables
Compare Cession Oncology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Onselex Pharmaceuticals | 86% | |
| Palto Therapeutics | 84% | |
| PushCART Therapeutics, Inc. | 74% |
Cession Oncology Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Cession Oncology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cession Oncology's valuation, stock price, and market status.
Is Cession Oncology a public or private company?
Cession Oncology is a private company.
What is the current stock price of Cession Oncology?
Cession Oncology is a private company with no public stock price. Caplight tracks Cession Oncology's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Cession Oncology worth (valuation)?
Valuation information for Cession Oncology is not publicly available.
Can I buy Cession Oncology stock?
Cession Oncology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cession Oncology's last funding round?
Funding round information for Cession Oncology is not publicly available.
Who are the main investors in Cession Oncology?
Investor information for Cession Oncology is not publicly disclosed.
Will Cession Oncology IPO soon?
No public IPO plans have been announced for Cession Oncology.
How can I track Cession Oncology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cession Oncology's secondary market activity and sign up for updates.